Similar to PDD and AD, neuropathological studies show that DLB subjects also exhibit amyloid-beta and tau pathology co-occurring with alpha-synuclein pathology, where approximately 40–70% harbor amyloid-beta plaques across studies (Vrillon et al., 2024). This evidence concerns the gene MAPT and Lewy body dementia.